Zorik Spektor - Net Worth and Insider Trading

Zorik Spektor Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zorik Spektor owns 1 companies in total, including Innovation Pharmaceuticals Inc (IPIX) .

Click here to see the complete history of Zorik Spektor’s form 4 insider trades.

Insider Ownership Summary of Zorik Spektor

Ticker Comapny Transaction Date Type of Owner
IPIX Innovation Pharmaceuticals Inc 2015-04-24 director

Zorik Spektor Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Zorik Spektor Ownership Network

Ownership Network List of Zorik Spektor

No Data

Ownership Network Relation of Zorik Spektor

Insider Network Chart

Zorik Spektor Owned Company Details

What does Innovation Pharmaceuticals Inc do?

Who are the key executives at Innovation Pharmaceuticals Inc?

Zorik Spektor is the director of Innovation Pharmaceuticals Inc. Other key executives at Innovation Pharmaceuticals Inc include Pres. & Chief Medical Officer Arthur Peter Bertolino , Vice President Jane A. Harness , and director & 10 percent owner & Chief Financial Officer Leo Ehrlich .

Innovation Pharmaceuticals Inc (IPIX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Innovation Pharmaceuticals Inc (IPIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovation Pharmaceuticals Inc (IPIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Innovation Pharmaceuticals Inc (IPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Innovation Pharmaceuticals Inc Insider Transactions

No Available Data

Zorik Spektor Mailing Address

Above is the net worth, insider trading, and ownership report for Zorik Spektor. You might contact Zorik Spektor via mailing address: 17615 Fieldbrook Circle E, Boca Raton Fl 33496.

Discussions on Zorik Spektor

No discussions yet.